Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-082685
Filing Date
2021-06-17
Accepted
2021-06-17 17:01:25
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119973-10_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2119973-10_3seq1.xml 3 4092
2 EXHIBIT 24.1 tm2119973d10_ex24-1.htm EX-24.1 6234
  Complete submission text file 0001104659-21-082685.txt   11724
Mailing Address TWO CORPORATE DRIVE C/O FIVE PRIME THERAPEUTICS, INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Borges Luis (Reporting) CIK: 0001684015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 211025552

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)